Mechanism Exploration of Dunyeguanxinning in the Treatment of Atherosclerosis Based on UPLC-Q-Orbitrap HRMS Technology, Network Pharmacology, Molecular Docking and Experimental Validation
DYGXN contains multiple saponins that exert anti-AS effects through the regulation of multiple targets and pathways.
Authors
- Jianwei Zhang (ORCID: https://orcid.org/0000-0002-2041-2542)
- Xuefei Shi (ORCID: https://orcid.org/0000-0002-8065-1887)
- Xiaolong Wang (ORCID: https://orcid.org/0000-0001-9906-5522)
- Qipeng Jin
- Dan Wang (ORCID: https://orcid.org/0000-0003-0945-7536)
Institutions
- Shanghai University of Traditional Chinese Medicine (CN)
- Shuguang Hospital (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-04-01
- DOI
- https://doi.org/10.2147/jir.s511604
- Primary Topic
- Traditional Chinese Medicine Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00